Authors/Disclosures
Nils Henninger, MD, PhD, FANA, FWSO
(UMass Memorial Medical Center)
|
Dr. Henninger has stock in United Health. Dr. Henninger has stock in Novo Nordisk. Dr. Henninger has stock in Elli Lilly. Dr. Henninger has stock in Kenvue. Dr. Henninger has stock in Voyager. Dr. Henninger has stock in Alnylam. The institution of Dr. Henninger has received research support from DoD. The institution of Dr. Henninger has received research support from NIH. Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Verge Genomics. Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Myrobalan Inc. |
|
No disclosure on file |
Marc Fisher, MD, FAAN
(Beth Israel Deaconess Medical Center)
|
Dr. Fisher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Fisher has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SimcereUSA. Dr. Fisher has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SimcereUSA. Dr. Fisher has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NoNo. Dr. Fisher has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. |
|
No disclosure on file |
Anat Mirelman
|
Anat Mirelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie . Anat Mirelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. The institution of Anat Mirelman has received research support from Department of Defense. The institution of Anat Mirelman has received research support from MJFF. The institution of Anat Mirelman has received research support from JPND. The institution of Anat Mirelman has received research support from EU-Horizon 2020. |